Nanomedicine: Techniques, potentials, and ethical implications

被引:54
作者
Ebbesen, Mette [1 ,2 ,3 ]
Jensen, Thomas G. [4 ]
机构
[1] Univ Aarhus, INANO, DK-8000 Aarhus C, Denmark
[2] Univ Aarhus, Ctr Bioeth, DK-8000 Aarhus C, Denmark
[3] Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA
[4] Kennedy Inst, DK-2600 Glostrup, Denmark
来源
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 2006年
关键词
D O I
10.1155/JBB/2006/51516
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Nanotechnology is concerned with materials and systems whose structures and components exhibit novel physical, chemical, and biological properties due to their nanoscale size. This paper focuses on what is known as nanomedicine, referring to the application of nanotechnology to medicine. We consider the use and potentials of emerging nanoscience techniques in medicine such as nanosurgery, tissue engineering, and targeted drug delivery, and we discuss the ethical questions that these techniques raise. The ethical considerations involved in nanomedicine are related to risk assessment in general, somatic-cell versus germline-cell therapy, the enhancement of human capabilities, research into human embryonic stem cells and the toxicity, uncontrolled function and self-assembly of nanoparticles. The ethical considerations associated with the application of nanotechnology to medicine have not been greatly discussed. This paper aims to balance clear ethical discussion and sound science and so provide nanotechnologists and biotechnologists with tools to assess ethical problems in nanomedicine. Copyright (C) 2006.
引用
收藏
页数:11
相关论文
共 65 条
[1]   Image-guided robotic radiosurgery [J].
Adler, JR ;
Murphy, MJ ;
Chang, SD ;
Hancock, SL .
NEUROSURGERY, 1999, 44 (06) :1299-1306
[2]   Engineering liver therapies for the future [J].
Allen, JW ;
Bhatia, SN .
TISSUE ENGINEERING, 2002, 8 (05) :725-737
[3]   Germ-line genetic enhancement and Rawlsian primary goods [J].
Allhoff, F .
KENNEDY INSTITUTE OF ETHICS JOURNAL, 2005, 15 (01) :39-56
[4]  
ANDERSEN S, 2006, IN PRESS MORAL RESPO
[5]  
[Anonymous], 1997, The Ethics of Human Gene Therapy
[6]  
Beauchamp TL, 2000, J MED PHILOS, V25, P342, DOI 10.1076/0360-5310(200006)25:3
[7]  
1-H
[8]  
FT342
[9]   A defense of the common morality [J].
Beauchamp, TL .
KENNEDY INSTITUTE OF ETHICS JOURNAL, 2003, 13 (03) :259-274
[10]  
BEAUCHAMP TL, 1995, KENNEDY INST ETHIC J, V5, P181